iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nanomedicine

• Publication date

  2017-07-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2217/nnm-2017-0107PMID 28745123PMCID PMC5551526
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicted Increases in Incidence of Colorectal Cancer in Developed and Developing Regions, in Association With Ageing Populations

  2017cited by this paper
• Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells.

  2016cited by this paper
• Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer.

  2016cited by this paper
• Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity.

  2016cited by this paper
• Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.

  2016cited by this paper
• Azo polymeric micelles designed for colon-targeted dimethyl fumarate delivery for colon cancer therapy.

  2016cited by this paper
• Combinatorial nanomedicines for colon cancer therapy.

  2016cited by this paper
• Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.

  2016cited by this paper
• AMP-guided tumour-specific nanoparticle delivery via adenosine A1 receptor.

  2016cited by this paper
• Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy.

  2016cited by this paper
• PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

  2016cited by this paper
• Construction of orthotopic xenograft mouse models for human pancreatic cancer.

  2015cited by this paper
• A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.

  2015cited by this paper
• Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.

  2015cited by this paper
• Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.

  2015cited by this paper
• Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.

  2015cited by this paper
• A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD

  2015cited by this paper
• Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

  2015cited by this paper
• A multifunctional role of trialkylbenzenes for the preparation of aqueous colloidal mesostructured/mesoporous silica nanoparticles with controlled pore size, particle diameter, and morphology.

  2015cited by this paper
• Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles.

  2015cited by this paper
• Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.

  2014cited by this paper
• A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity.

  2014cited by this paper
• Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer

  2014cited by this paper
• Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.

  2014cited by this paper
• Strategies for advancing cancer nanomedicine.

  2013cited by this paper
• ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

  2013cited by this paper
• Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer

  2013cited by this paper
• Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

  2013cited by this paper
• Non-fouling biomaterials based on blends of polyethylene oxide copolymers and polyurethane: simultaneous measurement of platelet adhesion and fibrinogen adsorption from flowing whole blood

  2013cited by this paper
• Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery

  2013cited by this paper
• Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.

  2012cited by this paper
• Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

  2011cited by this paper
• The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies

  2011cited by this paper
• Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.

  2011cited by this paper
• Chitosan-polycaprolactone copolymer microspheres for transforming growth factor-β1 delivery.

  2011cited by this paper
• An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis.

  2011cited by this paper
• PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.

  2011cited by this paper
• Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods critical comparison.

  2011cited by this paper
• Inflammation and colon cancer.

  2010cited by this paper
• Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation

  2010cited by this paper
• Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

  2010cited by this paper
• Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

  2010cited by this paper
• Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release

  2010cited by this paper
• Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.

  2010cited by this paper
• Design considerations for tumour-targeted nanoparticles.

  2010cited by this paper
• A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.

  2009cited by this paper
• Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.

  2009cited by this paper
• Potential of the biopolymer chitosan with different molecular weights to control postharvest gray mold of tomato fruit

  2009cited by this paper
• Tissue-penetrating delivery of compounds and nanoparticles into tumors.

  2009cited by this paper
• Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.

  2009cited by this paper
• Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.

  2008cited by this paper
• Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles.

  2008cited by this paper
• Practices and pitfalls of mouse cancer models in drug discovery.

  2007cited by this paper
• High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation.

  2006cited by this paper
• Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.

  2004cited by this paper
• Inflammation and necrosis promote tumour growth

  2004cited by this paper
• Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.

  2004cited by this paper
• Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

  2003cited by this paper
• PLGA/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading Ratio

  2003cited by this paper
• Luminescent CdSe Quantum Dot Doped Stabilized Micelles

  2002cited by this paper
• A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

  2001cited by this paper
• Structure and Applications of Poly(vinyl alcohol) Hydrogels Produced by Conventional Crosslinking or by Freezing/Thawing Methods

  2000cited by this paper
• Camptothecins: from bench research to hospital wards.

  1994cited by this paper
• Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity.

  1989cited by this paper

• An effective tumor-inhibiting siRNA delivery platform.

  2026cites this paper
• Advances in Homing Peptide Targeted Therapies

  2025influential citation
• Novel probe with iRGD integrated graphene oxide nanoparticles and labeled with 131I for detection of thyroid papillary carcinoma cells

  2025cites this paper
• Functional Peptides in Targeted Cancer Therapy: Mechanisms, Delivery Strategies, and Clinical Perspectives

  2025cites this paper
• iRGD-TRP-PK1-modified red blood cell membrane vesicles as a new chemotherapeutic drug delivery and targeting system in head and neck cancer

  2025cites this paper
• pH-Dependent Non-Covalent Release of Chemotherapy from Carriers

  2024cites this paper
• Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems

  2024influential citation
• Development of Chitosan‐Coated Graphene Oxide and Iron Oxide Nanocomposites for Targeted Delivery of Camptothecin to Liver Cancer Cells

  2024cites this paper
• Artificial Water Channel Promoting Depolymerization of Actin Filaments to Trigger Cancer Cell Apoptosis

  2024cites this paper
• Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle

  2023cites this paper
• Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.

  2023cites this paper
• Cancer therapy with iRGD as a tumor-penetrating peptide.

  2023cites this paper
• MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization

  2022cites this paper
• DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma

  2022cites this paper
• Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells.

  2022cites this paper
• Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.

  2022cites this paper
• pH-Triggered Poly(ethylene glycol)-Poly(lactic acid/glycolic acid)/Croconaine Nanoparticles-Assisted Multiplexed Photoacoustic Imaging and Enhanced Photothermal Cancer Therapy.

  2021cites this paper
• The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

  2021cites this paper
• Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment

  2021cites this paper
• Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review

  2021cites this paper
• Antitumor activity of iRGD-modified red blood cell membrane nanoparticles loaded with Juglone and Oxaliplatin against colorectal cancer

  2021cites this paper
• 9-amino acid cyclic peptide-decorated sorafenib polymeric nanoparticles for the efficient in vitro nursing care analysis of hepatocellular carcinoma

  2020cites this paper
• Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy

  2019cites this paper
• Orally Delivered Antisense Oligodeoxyribonucleotides of TNF‐α via Polysaccharide‐Based Nanocomposites Targeting Intestinal Inflammation

  2019cites this paper
• Cancer-Targeted PEDF-DNA Therapy for Metastatic Colorectal Cancer.

  2019cites this paper
• Aggregate Formation of BODIPY-Tethered Oligonucleotides That Led to Efficient Intracellular Penetration and Gene Regulation.

  2019cites this paper
• Special Section on Drug Delivery Technologies — Minireview Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer

  2019cites this paper
• Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment

  2019cites this paper
• Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer

  2019cites this paper
• Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases.

  2019cites this paper
• iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers

  2019cites this paper
• Targeted Delivery of Cell Penetrating Peptide Virus-like Nanoparticles to Skin Cancer Cells

  2018cites this paper
• A Specific Drug Delivery System for Targeted Accumulation and Tissue Penetration in Prostate Tumors Based on Microbially Synthesized PHBHHx Biopolyester and iRGD Peptide Fused PhaP.

  2018cites this paper
• Targeting metastatic colorectal cancer with PLGA nanoparticles carrying MACC1 siRNA

  2018cites this paper
• A triple modality BSA-coated dendritic nanoplatform for NIR imaging, enhanced tumor penetration and anticancer therapy.

  2018cites this paper
• Facile Fabrication of Oxidation-Responsive Polymeric Nanoparticles for Effective Anticancer Drug Delivery.

  2018cites this paper
• Seek & Destroy, use of targeting peptides for cancer detection and drug delivery.

  2017cites this paper